To: Anthony Wong who wrote (887 ) 10/9/1998 7:19:00 PM From: Anthony Wong Read Replies (1) | Respond to of 1722
Pfizer 3rd-Q Profit Seen at 57 Cents a Share: Earnings Outlook Bloomberg News October 9, 1998, 5:06 p.m. ET Expected Earnings Pfizer Inc.'s third-quarter earnings are expected to rise to 57 cents a share, the average estimate of analysts polled by First Call Corp. The drugmaker earned 46 cents a share in the year-earlier period. Time Pfizer, maker of the impotence pill Viagra and the antidepressant Zoloft, is expected to release earnings next week. Behind the Numbers Pfizer introduced two drugs this year, Viagra and the antibiotic Trovan. It also has been able to boost sales of its other drugs, such as the depression medicine Zoloft. Pfizer also helps market Warner-Lambert Co.'s blockbuster drug, the cholesterol reducer Lipitor. Introduced in 1997, Lipitor had second-quarter sales of $533 million. New York-based Pfizer intends to shed its medical-device businesses to focus on more profitable drug business. Last month, Pfizer sold two of these units for a combined $2.23 billion. It intends to sell a third medical-device business for $1.9 billion. What the Experts Say ''Look at the fundamentals of Pfizer,'' said Robert Flamm, an analyst with Evergreen Asset Management, which holds about 214,000 shares of the company. ''They're a marketing machine, they're a research machine. They know how to get products out.'' Previous Market Reaction Pfizer rose 2 1/2 to 116 on July 9 when it reported a 38 percent increase in profit, topping estimates. Viagra had an unprecedented U.S. introduction in April. Second-quarter sales reached $411 million as pharmacies stocked up on the drug and magazine and news reports helped raise demand. Market Trend Pfizer has dropped 19 percent to 93 since reporting second- quarter results. In the same period, the Standard & Poor's Drugs Index fell 5.5 percent and the Standard & Poor's 500 Index fell 15 percent. Pfizer fell as reported U.S. Viagra sales declined. Sales peaked at 308,631 prescriptions in the week ended May 8, according to NDC Health Information Services, which monitors pharmacy sales. Viagra sales seem to be increasing again, NDC said. In the week ended Oct. 2, 190,538 Viagra prescriptions were filled, up from 169,946 a week earlier, said NDC, a unit of Atlanta-based National Data Corp. --Kerry Dooley in the Princeton newsroom (609) 279-4016 /mfr